Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Business Update
Provided By GlobeNewswire
Last update: May 15, 2025
NORCROSS, Ga., May 15, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three months ended March 31, 2025.
Read more at globenewswire.com2.42
-0.87 (-26.44%)
Find more stocks in the Stock Screener
GALT Latest News and Analysis
10 hours ago - ChartmillThese stocks are moving in today's sessionKeep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
3 days ago - ChartmillThese stocks are moving in today's sessionKeep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
3 days ago - ChartmillWhich stocks are moving on Tuesday?Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
